Neftys Pharma, a leading French distributor of animal health products (730 employees, €555 million in revenue in 2025), is welcoming For Talents to its shareholder base alongside GENEO Capital Entrepreneur and UI Investissement, both of which are reinvesting in this new financing round to support the family’s generational handover and the company’s development, particularly internationally.
For Talents’ investment forms part of the handover from Jacques Mignot, the group’s founder, to his son Diego Mignot, currently Chief Executive Officer, who will become Chairman on May 1. He will succeed his father in that role.
Alongside the Mignot family, For Talents, a family-capital investment company whose mission is to increase the success rate of generational handovers in family businesses, is taking a minority stake to support this new structuring phase for the group, combining investment with tailored support for leaders navigating succession.
For their part, UI Investissement and GENEO Capital Entrepreneur, already minority shareholders for the past four years, are reinvesting and reaffirming their support for a project now even more strongly focused on international expansion, notably through the implementation of GENEO’s tailored growth playbook. This new investment reflects their confidence in Neftys Pharma’s strategy and management team.

Founded in 1987 by Jacques Mignot, Neftys Pharma has grown on the conviction that distribution plays a central role in creating value in the animal health market. Today, the group is reaching a new milestone with the transfer to the second generation.
This transition has been designed to ensure continuity of the family-led project while strengthening governance and equipping the group to deliver on its future ambitions, particularly internationally.
Neftys Pharma has established itself as a strategic partner to laboratories and animal health professionals.
Building on its longstanding logistics expertise, the group has gradually expanded its scope to become a comprehensive distribution platform capable of meeting the needs of all its partners.
Today, Neftys Pharma offers a full range of services spanning the entire value chain: logistics, marketing, data, digital, and strategic support for laboratories in accessing the market. Through this integrated approach, the group works every day to help ensure access to animal health solutions for professionals and animal owners.
Present in 8 countries in Europe (France, Portugal, Spain, Belgium, Poland, Croatia, Serbia and Slovenia) and 7 in Africa (Morocco, Senegal, Côte d’Ivoire, Nigeria, Burkina Faso, Niger and Mauritius), the group is pursuing an active growth strategy, illustrated by several acquisitions completed in recent years that have strengthened both its geographic footprint and its local positions.
Neftys Pharma aims to accelerate both organic and external growth through five major levers:
Neftys Pharma already benefits from a robust infrastructure:
This new capital structure for Neftys Pharma is intended to support the family’s generational handover and underpin the group’s development strategy.
In this context, Neftys Pharma is relying on For Talents, whose distinctive approach is designed to secure intergenerational handovers while supporting business leaders in their growth plans.
The operation also benefits from the support of the strategic partner Groupe Cristal and the group’s banking partners: Crédit Lyonnais (Agent and Coordinator), Caisse Régionale de Crédit Agricole Mutuel Centre France (Coordinator), Banque CIC Ouest, Banque Populaire Grand Ouest, BNP Paribas, CIC Lyonnaise de Banque, Banque Populaire Auvergne-Rhône-Alpes, Banque Populaire Rives de Paris, BRED Banque Populaire, Arkéa Banque Entreprises and Institutionnels, and La Banque Postale.
| Advisors to Neftys Pharma | Advisors to For Talents |
|---|---|
| Legal advisor: Volt (Emmanuel Vergnault) M&A advisor: Rothschild & Co (Philippe de Montreynaud) Management and tax advisor: Mayer Brown (Laurent Borey) Financing advisor: Mayer Brown (Maud Bischoff) Commercial vendor due diligence: Roland Berger (Julien Gautier) Financial vendor due diligence: Ernst & Young (Marc-André Audisio) Legal vendor due diligence: Squire Patton Boggs (Charles Fabry) Neftys Pharma team: Diego Mignot, Elisabeth Siachoua, Nicolas Lang. | Legal advisor: Jones Day (David Swinburne, Léon Bousset, Pauline Bilfeld) Financial due diligence: Interpath (Guilhem Maguin, Sahar Jilal, Yasmine Hadjeres, Maxime Pauquin) Legal, tax and social due diligence: Jones Day (David Swinburne, Emmanuel de La Rochethulon, Léon Bousset, GermainStarck, Pauline Bilfeld) ESG due diligence: Oderis (Radia Benhallam, Lucile Cotelle, Ghali Benkirane) For Talents team: Benjamin Teszner, Mathieu Mousseron and Sabine Decoster ; Blandine Pessin-Bazil and Bertrand Cunaud. |
| Advisors to GENEO Capital Entrepreneur Legal advisor: SVZ (Pierre-Emmanuel Chevalier, Chloé Métivier) GENEO Capital Entrepreneur team: François Picarle and Diane Lajaumont | Advisors to UI Investissement Legal advisor (De Pardieu Brocas Mattei): Cédric Chanas, Sandra Aloui, Alix Amaury, Albéric Duhamel-Delattre UI Investissement team: Stéphanie Pépineau, Olivier Jarrousse. |
Founded in 2021 by Matthieu Leclercq, former Chairman of the family-owned company Decathlon and founder of O’Tera, For Talents is a family-capital investment company serving family capital. As a mission-driven company, it is the first investment firm specialized in the pivotal moment of succession between two generations of a family business. Its mission is to increase the success rate of generational handovers in family businesses.
For Talents has developed a unique model combining a consistently minority investment, tailored human support for business leaders and corporate governance, and two investment tickets: one ranging from €30 million to €100 million, and another of €1 million for SMEs, in partnership with PurpleShares.
To date, For Talents has invested more than €750 million in 11 family-owned SMEs and mid-sized companies: Paprec, Groupe Petit Forestier, Riou Glass, Altavia, Biografy, Cofinas, BelEnergia, Groupe GPA, Sud Express, Leman Industries and Neftys Pharma. For Talents is made up of 15 committed experts from the business world, united by shared values of trust, simplicity and innovation.
More information: www.fortalents.com
NEFTYS PHARMA Group is a major distributor of veterinary products. Present in more than 15 countries across Europe and Africa, Neftys Pharma is an independent French family-owned group employing 730 people and generating €555 million in revenue in 2025. Its business is to distribute veterinary products across all channels: veterinary clinics, pharmacies, livestock cooperatives, garden centers, pet stores and e-commerce.
More information: www.neftys-pharma.com
Through its evergreen investment vehicle, GENEO Capital Entrepreneur provides agile capital that adapts to each company’s pace with responsiveness and flexibility. As a business partner, it delivers operational and human support for executing business plans through a tailored growth playbook for each company, together with access to specialized business partners and a network of experts. Its community of more than 260 families and entrepreneurs offers experience-sharing and a business network unlike any other in France.
More information: www.geneocapitalentrepreneur.com
An independent firm specializing in business development, UI has been committed for more than 50 years alongside the leaders of start-ups, SMEs and mid-sized companies to help create and grow businesses that are both economically successful and sustainably high performing.
UI Investissement manages more than €1.8 billion in assets and partners with more than 300 business leaders in sectors essential to society, such as healthcare, agribusiness, industry and services. Growth and transmission capital, the historic core of UI’s business, represents more than half of assets under management and enables more than 80 companies to benefit from UI’s operational expertise and methodological tools.
At the same time, teams and investment vehicles dedicated to innovation and consolidation help support businesses throughout their life cycle and contribute to the economic vitality of regional territories.
UI now relies on nearly 90 employees and, in addition to its Paris teams, on more than 10 regional offices (Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Limoges, Lyon, Nantes, Orléans, Reims, Rennes and Strasbourg).
More information: www.ui-investissement.fr